LifeX Ventures — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
HyperSpectral develops a spectral sensing and AI layer for Physical AI that interprets matter through spectral data, molecular identification, and AI architecture.
AI & Machine LearningDeep TechDefense TechHardwareAlexandria, US
Matthew Theurer(Executive Officer, Director)Lauren Stack(Executive Officer, Director)inVincent Lubsey(Executive Officer)
BoardJuan Lopez(Director)inWilliam Porteous(Director)in
Co-investorsKibo VenturesRRE VenturesAngelini VenturesGlade Brook Capital PartnersHeal CapitalThe Engine Ventures+1 more
Hypervision Surgical develops an intraoperative hyperspectral imaging system that uses AI to provide real-time, contrast-free tissue characterisation during surgery.
AI & Machine LearningHealthtechMedical Devices
PartnerInaki Berenguer· solo GP
Co-investorsHeal CapitalHeran PartnersMeridian Health VenturesSonorcapZEISS VenturesAngelini Ventures+2 more
Ilant Health provides value-based care for obesity and cardiometabolic disease, combining anti-obesity medications, bariatric procedures, behavioral change, and support from clinicians, dietitians, care navigators, and mental health professionals.
AI & Machine LearningDigital HealthHealthtechWellness & FitnessClaymont, US
Elina Onitskansky(Executive Officer, Director, Promoter)in
BoardAryeh Ganz(Director)Matthew Klitus(Director)
PartnerInaki Berenguer· solo GP
Co-investorsCeltic House Asia PartnersCity LightCornucopian Capital ManagementnaturalX Health VenturesPeakBridge VCInnovation Works
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
.png)

















